Jilin Jian Yisheng Pharmaceutical Co., Ltd.
SZSE:002566.SZ
8.52 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||||
Current Assets: | ||||||||||||||||||
Cash & Cash Equivalents
| 487.734 | 343.264 | 219.695 | 286.997 | 63.015 | 38.843 | 80.586 | 79.889 | 161.802 | 312.125 | 398.048 | 850.61 | 883.867 | 46.181 | 47.135 | 23.327 | 54.527 | 29.176 |
Short Term Investments
| 102.982 | 59.843 | 70.163 | 0 | 0 | 0 | 4 | 0 | 33 | 82 | 296.73 | 0 | 0 | 0 | 0 | 0 | 0 | 0.269 |
Cash and Short Term Investments
| 590.716 | 403.107 | 289.858 | 286.997 | 63.015 | 38.843 | 80.586 | 79.889 | 161.802 | 312.125 | 398.048 | 850.61 | 883.867 | 46.181 | 47.135 | 23.327 | 54.527 | 29.445 |
Net Receivables
| 210.996 | 289.851 | 281.19 | 294.739 | 261.283 | 263.819 | 276.958 | 307.049 | 353.193 | 363.421 | 340.964 | 310.038 | 354.012 | 185.863 | 156.302 | 161.18 | 133.344 | 226.959 |
Inventory
| 1,616.748 | 1,603.101 | 1,596.872 | 1,615.762 | 1,633.711 | 1,679.396 | 1,666.234 | 1,621.781 | 1,448.653 | 1,212.01 | 475.558 | 195.28 | 133.84 | 98.524 | 68.826 | 70.937 | 62.253 | 59.223 |
Other Current Assets
| 12.607 | 6.554 | 53.873 | 25.858 | 25.152 | 32.505 | 93.557 | 147.608 | 190.949 | 207.31 | 324.845 | 10.01 | -22.513 | -17.623 | -18.508 | -17.603 | -16.803 | -77.004 |
Total Current Assets
| 2,431.067 | 2,302.613 | 2,221.793 | 2,223.356 | 1,983.16 | 2,014.563 | 2,117.335 | 2,156.326 | 2,154.598 | 2,094.866 | 1,539.413 | 1,365.938 | 1,349.205 | 312.945 | 253.756 | 237.84 | 233.321 | 238.623 |
Non-Current Assets: | ||||||||||||||||||
Property, Plant & Equipment, Net
| 484.931 | 526.11 | 501.486 | 423.296 | 430.526 | 460.602 | 458.121 | 438.359 | 398.36 | 295.954 | 279.491 | 230.261 | 207.803 | 185.166 | 160.13 | 100.191 | 97.433 | 89.419 |
Goodwill
| 1.906 | 1.906 | 1.906 | 1.906 | 1.906 | 1.906 | 1.906 | 1.906 | 1.906 | 1.906 | 1.906 | 1.906 | 1.906 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 114.183 | 117.025 | 119.957 | 123.412 | 54.738 | 55.334 | 57.286 | 58.521 | 60.139 | 16.427 | 16.477 | 17.397 | 15.25 | 11.771 | 9.223 | 6.823 | 7.275 | 6.827 |
Goodwill and Intangible Assets
| 116.088 | 118.931 | 121.863 | 125.318 | 56.644 | 57.24 | 59.192 | 60.427 | 62.045 | 18.333 | 18.383 | 19.302 | 17.156 | 11.771 | 9.223 | 6.823 | 7.275 | 6.827 |
Long Term Investments
| 0 | 0 | 2.989 | 4.096 | 2.475 | 0.748 | 1.329 | 2.101 | 1.228 | 1.794 | 1.921 | 1.035 | 0 | 0 | 0 | 0 | 0 | -0.176 |
Tax Assets
| 12.619 | 14.202 | 15.198 | 17.868 | 16.159 | 14.88 | 14.346 | 10.963 | 12.445 | 8.898 | 7.647 | 5.276 | 4.467 | 5.162 | 4.45 | 2.334 | 3.461 | 2.896 |
Other Non-Current Assets
| 2.017 | 4.752 | 1.038 | 2.165 | 7.55 | 5.069 | 3.163 | 2.544 | 5.049 | 70.502 | 43.8 | 40.361 | 0 | 0.016 | 0.106 | 0.135 | 0.181 | 0.456 |
Total Non-Current Assets
| 615.655 | 663.994 | 642.574 | 572.743 | 513.353 | 538.539 | 536.151 | 514.394 | 479.127 | 395.481 | 351.242 | 296.235 | 229.426 | 202.114 | 173.909 | 109.483 | 108.349 | 99.422 |
Total Assets
| 3,046.722 | 2,966.607 | 2,864.367 | 2,796.099 | 2,496.514 | 2,553.101 | 2,653.486 | 2,670.721 | 2,633.726 | 2,490.347 | 1,890.655 | 1,662.173 | 1,578.63 | 515.059 | 427.665 | 347.322 | 341.67 | 338.045 |
Liabilities & Equity: | ||||||||||||||||||
Current Liabilities: | ||||||||||||||||||
Account Payables
| 24.865 | 24.326 | 19.813 | 24.801 | 25.572 | 21.436 | 25.603 | 19.989 | 24.143 | 134.598 | 19.649 | 18.093 | 12.119 | 7.34 | 10.02 | 6.585 | 4.307 | 6.529 |
Short Term Debt
| 472.337 | 433.721 | 403.718 | 415.402 | 280.47 | 430.38 | 540.38 | 710.38 | 760.38 | 480.38 | 100.38 | 1.13 | 1.13 | 40 | 23.75 | 71 | 67 | 53.108 |
Tax Payables
| 2.779 | 18.821 | 30.391 | 15.824 | 15.68 | 11.669 | 16.457 | 9.042 | 16.791 | 2.884 | 9.526 | 4.367 | 2.416 | 11.282 | 4.352 | 11.951 | 23.735 | 5.846 |
Deferred Revenue
| 11.011 | 24.509 | 108.047 | 129.093 | 54.701 | 11.669 | 137.821 | 101.469 | 66.691 | 71.907 | 57.839 | 33.822 | 32.7 | 89.13 | 77.724 | 37.641 | 49.763 | 25.106 |
Other Current Liabilities
| 81.632 | 105.608 | 2.17 | 5.226 | 35.266 | 78.731 | 14.643 | 5.813 | 6.097 | 16.259 | 3.465 | 2.416 | 0.812 | 2.246 | 19.548 | 0.807 | 1.435 | 0.949 |
Total Current Liabilities
| 589.845 | 588.165 | 533.748 | 574.522 | 396.009 | 542.216 | 718.447 | 837.651 | 857.311 | 703.145 | 181.333 | 55.462 | 46.762 | 138.716 | 131.043 | 116.033 | 122.506 | 85.691 |
Non-Current Liabilities: | ||||||||||||||||||
Long Term Debt
| 4.026 | 9.825 | 11.463 | 2.55 | 12.55 | 10.47 | 0.85 | 1.23 | 1.61 | 1.99 | 2.37 | 2.75 | 3.88 | 3.89 | 4.27 | 8.77 | 11.77 | 13.662 |
Deferred Revenue Non-Current
| 118.694 | 118.023 | 120.846 | 86.792 | 30.103 | 34.808 | 37.105 | 30.79 | 29.726 | 34.101 | 0 | 0 | 0 | 0 | 0 | 2.632 | 1.807 | 0 |
Deferred Tax Liabilities Non-Current
| 1.736 | 1.166 | 0.024 | 2.55 | -12.55 | -10.47 | -0.85 | -1.23 | -1.61 | -1.99 | 0 | 0 | 0 | 0 | 0 | -2.632 | -11.77 | 0 |
Other Non-Current Liabilities
| -118.694 | 0 | 0 | -2.55 | 12.55 | 10.47 | 0.85 | 1.23 | 1.61 | 1.99 | 30.091 | 14.602 | 13.875 | 13.055 | 11.361 | 2.632 | 11.77 | 0 |
Total Non-Current Liabilities
| 5.763 | 129.014 | 132.334 | 89.342 | 42.653 | 45.278 | 37.955 | 32.02 | 31.336 | 36.091 | 32.461 | 17.352 | 17.755 | 16.945 | 15.631 | 11.402 | 13.577 | 13.662 |
Total Liabilities
| 595.608 | 717.179 | 666.082 | 663.865 | 438.662 | 587.494 | 756.402 | 869.671 | 888.647 | 739.236 | 213.794 | 72.814 | 64.517 | 155.661 | 146.674 | 127.435 | 136.082 | 99.353 |
Equity: | ||||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 330.952 | 330.952 | 330.952 | 330.952 | 330.952 | 330.952 | 330.952 | 330.952 | 330.952 | 330.952 | 220.634 | 220.634 | 110.317 | 82.717 | 61.272 | 61.272 | 51.06 | 51.06 |
Retained Earnings
| 927.307 | 857.195 | 795.41 | 719.802 | 662.061 | 589.836 | 539.987 | 483.549 | 475.569 | 486.704 | 420.463 | 343.268 | 278.045 | 190.897 | 142.846 | 87.836 | 87.88 | 125.334 |
Accumulated Other Comprehensive Income/Loss
| 181.096 | 173.023 | 161.64 | 151.156 | 145.384 | 141.01 | 138.166 | 132.566 | 127.351 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 793.809 | 793.809 | 793.809 | 793.809 | 793.809 | 793.809 | 793.809 | 793.809 | 790.868 | 912.838 | 1,015.051 | 1,004.928 | 1,105.904 | 85.111 | 76.159 | 70.041 | 65.904 | 62.298 |
Total Shareholders Equity
| 2,233.163 | 2,154.978 | 2,081.81 | 1,995.718 | 1,932.205 | 1,855.607 | 1,802.913 | 1,740.875 | 1,724.739 | 1,730.494 | 1,656.149 | 1,568.83 | 1,494.267 | 358.725 | 280.278 | 219.149 | 204.844 | 238.692 |
Total Equity
| 2,332.421 | 2,249.428 | 2,198.284 | 2,132.234 | 2,057.852 | 1,965.607 | 1,897.084 | 1,801.05 | 1,745.078 | 1,751.111 | 1,676.861 | 1,589.359 | 1,514.113 | 359.398 | 280.991 | 219.888 | 205.587 | 238.692 |
Total Liabilities & Shareholders Equity
| 3,046.722 | 2,966.607 | 2,864.367 | 2,796.099 | 2,496.514 | 2,553.101 | 2,653.486 | 2,670.721 | 2,633.726 | 2,490.347 | 1,890.655 | 1,662.173 | 1,578.63 | 515.059 | 427.665 | 347.322 | 341.67 | 338.045 |